Publications

July 2001 (Revised August 2005)
Case

Medicines Company, The

By: John T. Gourville

It is early 2001 and the Medicines Co. just received FDA approval to market Angiomax, a blood thinner to be used during angioplasties and heart procedures. It is intended to be a better alternative to Heparin, an 80-year-old drug that costs less then $10 per dose. The... View Details

Keywords: Business Model; Change Management; Decision Choices and Conditions; Cost Management; Price; Product Marketing; Product Launch; Product Development; Risk and Uncertainty; Health Industry; Pharmaceutical Industry

December 2020 (Revised March 2022)
Case

Thinx, Inc.—Breaking Barriers in Feminine Care (Abridged)

By: Rembrand Koning, Elie Ofek and Nicole Tempest Keller

An examination of the strategic marketing challenges facing Thinx as it tries to grow in the face of menstruation taboos and competition from large incumbents. View Details

Keywords: Entrepreneurship; Innovation and Invention; Growth and Development Strategy; Marketing Strategy; United States

March 2020 (Revised November 2020)
Case

Thinx, Inc.—Breaking Barriers in Feminine Care

By: Rembrand Koning, Elie Ofek and Nicole Keller

An examination of the strategic marketing challenges facing Thinx as it tries to grow in the face of menstruation taboos and competition from large incumbents. View Details

Keywords: Entrepreneurship; Innovation and Invention; Growth and Development Strategy; Marketing Strategy; United States

08 Feb 2000
Research & Ideas

Building Effective R&D Capabilities Abroad

relevant markets and existing corporate facilities. It also determined that the initial laboratory leader would have to be an experienced manager from Lilly's home base—a manager with a deep understanding of... View Details

Keywords: by Walter Kuemmerle

February 2020
Case

Intellectual Ventures Update 2020

By: David B. Yoffie and Daniel Fisher

After raising $6 billion and buying 60,000 patents, Intellectual Venture (IV) was confronted with a changing legal environment. After a number of important legal decisions, including the Supreme Court's so-called "Alice" decision, IV had to shift strategy. IV sold off... View Details

Keywords: Intellectual Property; Strategy; Innovation and Invention; Information Technology; Business Model; United States

11 May 2010
First Look

First Look: May 11

Standard theories of corporate ownership assume that because markets are efficient, insiders ultimately bear agency costs and therefore have a strong incentive to minimize conflicts View Details

Keywords: Martha Lagace

6:30 PM – 8:30 PM CDT, 21 May 2015

Mexico City Alumni: Determine Your Career Elements & Connect with HBS

Join members of HBS Career & Professional Development (CPD) and fellow HBS alumni to network and gain insight on key HBS innovations and initiatives. Kristen Fitzpatrick, Managing Director of CPD will share resources available to you and guide you through a quick... View Details

27 Dec 2010
News

HBS Faculty on 2010's Biggest Business Developments

July 2002 (Revised August 2002)
Case

Washington Hospital Center (A): Rescuing Emergency Medicine

By: Rosabeth M. Kanter and Michelle Heskett

Dr. Craig Feied and Dr. Mark Smith, recruited to turn around the Washington Hospital Center Emergency Department, prepare to roll out their most revolutionary change yet--an information system that could radically improve the practice of emergency medicine. A review of... View Details

Keywords: Change Management; Health Care and Treatment; Nonprofit Organizations; Medical Specialties; Organizational Culture; Crisis Management; Technological Innovation; Higher Education; Health Industry; District of Columbia

April 1998 (Revised October 1998)
Background Note

Indonesia's Pharmaceutical Industry in 1998

By: Carin-Isabel Knoop and Anthony St. George

This case describes the Indonesian pharmaceutical market in 1997 and the impact on the market of the Indonesian rupiah's 75% devaluation since July 1997. Major foreign and domestic players are described. It raises the issue of how the Indonesian pharmaceutical market... View Details

Keywords: Financial Crisis; Pharmaceutical Industry; Indonesia

Find at Harvard

24 Jan 2024
Op-Ed

Why Boeing’s Problems with the 737 MAX Began More Than 25 Years Ago

the name of shareholder value over the past two decades have cost its investors $87 billion since 2018. The long-term damage to Boeing’s reputation and market position is even greater as Airbus has outsold... View Details

Keywords: by Bill George; Air Transportation; Transportation; Aerospace

March 2008
Case

Shangri-La Hotels

By: Dennis Campbell and Brent Kazan

In November 2006, Symon Bridle, the newly appointed chief operating officer of Shangri-La Hotels and Resorts, was thinking about a number of organizational issues that presented challenges to Shangri-La's rapid expansion strategy. There were three major issues at hand:... View Details

Keywords: Employees; Growth and Development Strategy; Standards; Service Delivery; Organizational Culture; Accommodations Industry; China; Europe; North America

11 May 2017
News

New Journal Sponsored by Top MBA Programs Tackles Critical Healthcare Management Issues

2016
Working Paper

Shareholder Activism on Sustainability Issues

By: Jody Grewal, George Serafeim and Aaron Yoon

Shareholder activism on sustainability issues has become increasingly prevalent over the years, with the number of proposals filed doubling from 1999 to 2013. We use recent innovations in accounting standard setting to classify 2,665 shareholder proposals that address... View Details

Keywords: Sustainability; Activism; Activist Investors; Activist Shareholder; Corporate Social Responsibility; Environment; Corporate Performance; Corporate Accountability; Corporate Social Responsibility and Impact; Performance; Environmental Sustainability; Corporate Governance; Business and Shareholder Relations; Investment Activism

SSRN

Jerry R. Green

David A. Wells Professor of Political Economy

John Leverett Professor in the University

Harvard University

Jerry Green is the John Leverett Professor in the University and the David A. Wells... View Details

Keywords: aerospace; education industry; insurance industry; professional services

02 Mar 2018
HBS Seminar

William F. Maloney, World Bank, Chief Economist, Equitable Growth, Finance and Institutions

01 Jun 2013
News

Collective Wisdom: Crowdsourcing for innovation, efficiency, and profit

October 2009 (Revised July 2013)
Case

Gilead Sciences, Inc.: Access Program

By: V. Kasturi Rangan and Katharine Lee

Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients... View Details

Keywords: Health Care and Treatment; Emerging Markets; Product; Sales; Competitive Strategy; Biotechnology Industry; Pharmaceutical Industry